MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis pat...
MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Even though anti-interferon beta (IFNβ) antibodies are the main determinants of IFNβ bioactivity loss and Myxovirus-resistance protein A (MxA) is the most established marker of IFNβ biological activity in IFNβ-treated multiple sclerosis patients, their usefulness in the routine clinical practice is still debated. Therefore, 118 multiple sclerosis p...
Alternative Titles
Full title
MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1516459870
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1516459870
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0094794
